42 parallel-programming-"Multiple"-"Simons-Foundation" PhD positions at Nature Careers in Germany
Sort by
Refine Your Search
-
programming skills are expected. General requirements: very good university degree (M.Sc. or equivalent) in chemistry, physics, or materials sciences; specialization theoretical chemistry/physics, condensed
-
: 01.10.2025 Application deadline: 03.09.2025 Tasks Execution of experimental work in a mouse model of cortical multiple sclerosis Application of in vivo imaging and quantitative analysis methods Investigation
-
candidates with disabilities. If multiple candidates prove to be equally qualified, those with disabilities or with equivalent status pursuant to the German Social Code IX (SGB IX) will receive priority
-
social challenges of Advanced Air Mobility (AAM), considering ecological, economic, technological, and sociological factors. The RTG's structured PhD program aims to train young researchers in highly
-
Graduate School as well as becoming a member of the TU Dresden’ Graduate Academy. Both will offer tailored educational programs and individual supervision agreements. In addition, TUD offers: employment in
-
program providing broad interdisciplinary training and education Opportunity to develop your individual skillset Intensive support, mentoring and career development Secondments in partner institute abroad
-
histopathological evaluation Statistical programming languages like R or Python Good communication skills in English; proficiency in German desirable but not required Willingness to work independently while
-
, Biomedical Imaging, or a related field A strong interest in molecular imaging (PET) and magnetic resonance imaging Experience with programming (Python, C++, Matlab) A keen interest in experimental work, as the
-
The University of Marburg, founded in 1527, offers a variety of excellent programs of study for around 22,000 students and confronts the important topics of our time through excellent research
-
). Understanding these immune-modulating effects is essential to optimize ADC-based therapies. In our study, we plan to systematically investigate two clinically relevant HER2-targeting ADCs, each bearing distinct